Porton Pharma Solutions Ltd.

About Porton Pharma Solutions Ltd.

With over 5,000 customer-centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecule APIs, dosage forms and biologics. By efficiently advancing development and enabling commercialization of multiple high-impact therapies, Porton is proud to have earned the trust of some of the world’s leading and most innovative pharmaceutical companies in the world.

  • CN
  • 2015
    On CPHI since
  • 3
  • 1000 - 4999
Company types
Contract Service
Contact info
Meet us at

CPHI Japan 2024

East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
17 Apr 2024 – 19 Apr 2024

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Porton Pharma Solutions Ltd. (3)

  • API CDMO Service
  • Biologics CDMO Service

    Product Biologics CDMO Service

    Gene and Cell Therapy Service  Porton provides world-class process development and manufacturing services for DNA plasmids, viral vectors and cell therapeutics e.g. Car-T backed by state of the art laboratories including BSL-2 laboratories high-quality cGMP production assets operated to global regulat...
  • Drug Product CDMO Service

    Product Drug Product CDMO Service

    Synergizing with US site for global clients, Porton has established end-to-end drug product CDMO platform, integrating global experts and formulation development technologies. The core technology team has experience of over 30 years in big pharma companies and drug product industry. The core R&D, techn...

Porton Pharma Solutions Ltd. Resources (1)